Stephane Chevaliez

Prof. Stephane Chevaliez

Henri Mondor hospital
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2015 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ASAlexandre Soulier
Alexandre Soulier
LPLila Poiteau
Lila Poiteau
IRIsabelle Rosa
Isabelle Rosa
CHChristophe Hézode
Christophe Hézode
FRFrançoise Roudot-Thoraval
Françoise Roudot-Thoraval
Stephane ChevaliezStephane Chevaliez
Stephane Chevaliez
Background. With the advent of highly efficient antiviral therapies for hepatitis C virus (HCV) infection, providing broad access to diagnosis and care is needed. The dried blood spot (DBS) technique can be used to collect, store, and ship whole-blood specimens. Our goal was to assess the performance of standardized HCV diagnostic and monitoring tools in the analysis of DBS. Methods. Serum specimens and whole-blood specimens collected using the DBS technique from >500 patients were tested for virological markers used to diagnose and monitor HCV infection. Results. Enzyme immunoassay detection of anti-HCV antibodies in specimens from DBS was reliable after establishment of a new signal-to-cutoff ratio. HCV RNA was detected DBS from the vast majority of patients with active replication, but HCV RNA levels were substantially lower than in serum specimens, implying that only the presence or absence of HCV RNA or changes in the HCV RNA level should be taken into consideration for therapy. Detection of HCV core antigen in specimens from DBS was not a sensitive marker of chronic HCV infection. HCV genotype determination was possible in the vast majority of DBS. Conclusions. This study shows that whole-blood specimens collected using the DBS technique can be confidently used to diagnose and monitor HCV infection. DBS could help improve access to care for HCV infection because they are suitable for use in large-scale screening programs, diagnosis, and therapeutic monitoring.

1 October 2018 in Journal of Hepatology
Verified
Journal Article
Closed access
Stephane ChevaliezStephane Chevaliez
Stephane Chevaliez
JPJean-Michel Pawlotsky
Jean-Michel Pawlotsky

11 April 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
FGfor the ANRS-Prevagay group
for the ANRS-Prevagay group
SVSophie Vaux
Sophie Vaux
Stephane ChevaliezStephane Chevaliez
Stephane Chevaliez
LSLeïla Saboni
Leïla Saboni
CSClaire Sauvage
Claire Sauvage
AVAnnie Velter
Annie Velter
Over the last 20 years, Hepatitis C virus (HCV) infection prevalence has dramatically increased among HIV-infected men who have sex with men (MSM) in many countries worldwide. It is suspected that this increase is primarily driven by sexual behaviours linked to blood exposure. Monitoring these behaviours is crucial to understand the drivers of the epidemic. This study assessed the prevalence of chronic HCV infection among MSM attending gay venues and associated chronic HCV risk factors. HCV screening and associated factors were described. The cross-sectional survey PREVAGAY, based on time-location sampling, was conducted in 2015 among MSM attending gay venues in 5 French metropolitan cities. A self-administered questionnaire was completed and capillary whole blood on dried blood spots (DBS) collected. Possible factors associated with chronic HCV prevalence and with HCV screening in the previous year were investigated using Poisson regression. Chronic HCV infection prevalence from DBS analysis was 0.7% [IC95%: 0.3–1.5] in the study’s 2645 participants and was 3.0% [1.5–5.8] in HIV-positive MSM. It was significantly higher in those who reported the following: (lifetime) slamming (with or without the sharing of injection equipment); (during the previous year) fisting and chemsex, unprotected anal intercourse with casual partners, using gay websites and/or of mobile-based GPS applications, and having more than 10 sexual partners. Only 41.3% [38.2–44.5] of the participants reported HCV screening during the previous year. Screening was significantly more frequent in MSM under 30 years of age, those who were HIV-positive, those vaccinated against hepatitis B and meningococcus C, and those who reported the following (during the previous year): more than 10 sexual partners, at least one sexually transmitted infection and fisting. Chronic HCV infection prevalence in MSM attending gay venues was significantly higher in HIV-positive MSM and in those with risky sexual behaviours. Reflecting current screening recommendations for specific populations, previous HCV screening was more frequent in HIV-positive individuals and those with risky sexual behaviours. Nevertheless, HCV screening coverage needs to be improved in these populations. Comprehensive medical management, which combines screening and linkage to care with prevention strategies, is essential to control HCV among MSM.

22 April 2019 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
Stephane ChevaliezStephane Chevaliez
Stephane Chevaliez
Introduction: The improvement of number of people diagnosed with hepatitis C virus (HCV) infection are crucial to reach the WHO objectives for eliminating viral hepatitis by 2030. Alternatives to classical HCV virological tests using serum or plasma taken from venous puncture including point-of-care (POC) tests and dried blood spot (DBS) are being considering for HCV screening, diagnosis and monitoring. Reflex nucleic acid testing and HCV core antigen test have the potential to simplify diagnostic algorithm, increase diagnosis and facilitate linkage to care. Areas covered: This review examines strategies for the improvement of HCV testing and diagnosis including alternatives to classical HCV virological tests and approaches for simplified diagnostic algorithms. Expert opinion: Serological and molecular POC tests are now available for HCV antibody and HCV RNA detection in less than 20 and 60 respectively. DBS offer the main advantage to store desiccated blood that can be easily transported to reference centers where state-of-the-art molecular and serological diagnostic tests are used. Simplifications of diagnostic algorithms are urgently needed to enhance HCV testing, linkage to care and treatment.

1 May 2020 in International Journal of Drug Policy
Verified
Journal Article
Closed access
PTPhilippe Trouiller
Philippe Trouiller
AVAnnie Velter
Annie Velter
LSLeïla Saboni
Leïla Saboni
CSCécile Sommen
Cécile Sommen
CSClaire Sauvage
Claire Sauvage
MJMarie Jauffret-Roustide
Marie Jauffret-Roustide

1 May 2016 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
Stephane ChevaliezStephane Chevaliez
Stephane Chevaliez
LPL. Poiteau
L. Poiteau
IRI. Rosa
I. Rosa
ASA. Soulier
A. Soulier
FRF. Roudot-Thoraval
F. Roudot-Thoraval
JPJ.-M. Pawlotsky
J.-M. Pawlotsky